A powerhouse team of researchers from UNC Lineberger has revealed that an implantable device can deliver a particularly toxic cocktail of drugs directly to pancreatic tumors to stunt their growth or in some cases, shrink them – all while showing signs that the rest of the body would be spared toxic side effects.
In response to low national vaccination rates for the human papillomavirus (HPV), we've joined 68 other cancer centers in issuing a statement urging for increased HPV vaccination for the prevention of cancer.
Based on a survey of widowed fathers who had lost a spouse to cancer, UNC Lineberger researchers reported in the journal BMJ Palliative Care that additional research and improved end-of-life care are needed to specifically help dying parents as well as their families.
Blue Cross Blue Shield of North Carolina is empowering the people of our state to LIVE FEARLESS. Pledge to Live Fearless today, choose UNC Lineberger as your team, and help win funding for NC's only public comprehensive cancer center.
UNC Lineberger’s application for renewal of a major five-year, federal grant earned an "exceptional" rating from the NCI. The rating is the highest that a cancer center can earn, ranking us among the best cancer centers of all time.